Nutrien Stock Forecast, Price & News

Nutrien's stock was trading at $32.00 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, NTR shares have increased by 67.6% and is now trading at $53.64.
View which stocks have been most impacted by COVID-19.

19 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Nutrien in the last twelve months. There are currently 1 sell rating, 6 hold ratings, 11 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" Nutrien stock.
View analyst ratings for Nutrien or view MarketBeat's top 5 stock picks.

Wall Street analysts have given Nutrien a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Nutrien wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Nutrien is scheduled to release its next quarterly earnings announcement on Tuesday, February 16th 2021.
View our earnings forecast for Nutrien.

Nutrien Ltd. (NYSE:NTR) announced its earnings results on Monday, November, 2nd. The company reported $0.23 EPS for the quarter, topping analysts' consensus estimates of $0.07 by $0.16. The business earned $4.21 billion during the quarter, compared to analyst estimates of $3.83 billion. Nutrien had a return on equity of 4.19% and a net margin of 0.47%. The firm's revenue was up .9% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.24 earnings per share.
View Nutrien's earnings history.

Nutrien announced a quarterly dividend on Thursday, December 10th. Shareholders of record on Thursday, December 31st will be given a dividend of $0.346 per share on Thursday, January 14th. This represents a $1.38 dividend on an annualized basis and a dividend yield of 2.58%. The ex-dividend date of this dividend is Wednesday, December 30th.
View Nutrien's dividend history.

Nutrien pays an annual dividend of $1.80 per share and currently has a dividend yield of 3.38%. Nutrien does not yet have a strock track record of dividend growth. The dividend payout ratio of Nutrien is 82.95%. Payout ratios above 75% are not desirable because they may not be sustainable. Based on EPS estimates, Nutrien will have a dividend payout ratio of 79.65% in the coming year. This indicates that Nutrien may not be able to sustain their current dividend.
View Nutrien's dividend history.

Nutrien updated its FY 2020 After-Hours earnings guidance on Monday, November, 2nd. The company provided earnings per share (EPS) guidance of 1.60-1.85 for the period.

19 brokerages have issued 1-year price targets for Nutrien's stock. Their forecasts range from $40.00 to $58.00. On average, they anticipate Nutrien's stock price to reach $49.00 in the next twelve months. This suggests that the stock has a possible downside of 8.7%.
View analysts' price targets for Nutrien or view Wall Street analyst' top-rated stocks.

Nutrien saw a decrease in short interest in December. As of December 31st, there was short interest totaling 5,300,000 shares, a decrease of 20.2% from the December 15th total of 6,640,000 shares. Based on an average daily volume of 1,380,000 shares, the short-interest ratio is currently 3.8 days. Currently, 0.9% of the company's stock are sold short.
View Nutrien's Short Interest.

Some companies that are related to Nutrien include The Scotts Miracle-Gro (SMG), The Mosaic (MOS), CF Industries (CF), ICL Group (ICL), American Vanguard (AVD), Bioceres Crop Solutions (BIOX), Calyxt (CLXT), Marrone Bio Innovations (MBII), CVR Partners (UAN), Evogene (EVGN), Wynnstay Group Plc (WYN.L) (WYN), Eden Research plc (EDEN.L) (EDEN), China Green Agriculture (CGA), Bion Environmental Technologies (BNET) and SenesTech (SNES).
View all of NTR's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Nutrien investors own include AT&T (T), Pfizer (PFE), Johnson & Johnson (JNJ), General Electric (GE), Intel (INTC), Bank of America (BAC), CVS Health (CVS), AbbVie (ABBV), JPMorgan Chase & Co. (JPM) and Micron Technology (MU).

Nutrien trades on the New York Stock Exchange (NYSE) under the ticker symbol "NTR."

Nutrien's stock is owned by a number of institutional and retail investors. Top institutional investors include Livingston Group Asset Management CO operating as Southport Capital Management (0.05%), Hexavest Inc. (0.04%), Signature Wealth Management Group (0.01%), Crossmark Global Holdings Inc. (0.01%), Raymond James Trust N.A. (0.01%) and Pacifica Partners Inc. (0.00%).

NTR stock was sold by a variety of institutional investors in the last quarter, including Hexavest Inc., Livingston Group Asset Management CO operating as Southport Capital Management, DAVENPORT & Co LLC, and Huntington National Bank.

NTR stock was acquired by a variety of institutional investors in the last quarter, including Signature Wealth Management Group, Raymond James Trust N.A., Pacifica Partners Inc., Fruth Investment Management, and Crossmark Global Holdings Inc..

Shares of NTR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of NTR stock can currently be purchased for approximately $53.64.

Nutrien has a market capitalization of $30.53 billion and generates $20.02 billion in revenue each year. The company earns $992 million in net income (profit) each year or $2.17 on an earnings per share basis. Nutrien employs 22,300 workers across the globe.

The official website for Nutrien is www.nutrien.com.

Nutrien's mailing address is SUITE 500 122 - 1ST AVENUE SOUTH, SASKATOON A9, S7K 7G3. The company can be reached via phone at 306-933-8500 or via email at [email protected]